The search for new antigenic targets in myasthenia gravis-Reference-Cited by-同舟云学术

The search for new antigenic targets in myasthenia gravis

Published:2012-12 Issue:1 Volume:1275 Page:123-128
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Cossins Judith,Belaya Katsiaryna,Zoltowska Katarzyna,Koneczny Inga,Maxwell Susan,Jacobson Leslie,Leite Maria Isabel,Waters Patrick,Vincent Angela,Beeson David

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2012.06833.x/fullpdf

Reference38 articles.

1. Autoimmune disorders of the neuromuscular junction;Lang;Curr. Opin. Pharmacol.,2009

2. ACh receptor-rich membrane domains organized in fibroblasts by recombinant 43-kildalton protein;Phillips;Science,1991

3. Myasthenia gravis and myasthenic syndromes;Engel;Ann. Neurol.,1984

4. Modulation of acetylcholine receptor by antibody against the receptor;Heinemann;Proc. Natl. Acad. Sci. USA,1977

5. Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors;Weinberg;Proc. Natl. Acad. Sci. USA,1979

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis;International Journal of Molecular Sciences;2023-12-28

2. Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis;Journal of Clinical Neurology;2023

3. Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders;The Lancet Neurology;2022-02

4. Eculizumab treatment for myasthenia gravis subgroups: 2021 update;Journal of Neuroimmunology;2022-01

5. Heterogeneity in myasthenia gravis: considerations for disease management;Expert Review of Clinical Immunology;2021-06-22